Your browser doesn't support javascript.
loading
SARS-CoV-2 seroprevalence and living conditions in Bamako (Mali): a cross-sectional multistage household survey after the first epidemic wave, 2020.
Mady Cissoko; Jordi Landier; Bourema Kouriba; Abdoul Karim Sangare; Abdoulaye Katile; Abdoulaye Djimde; Ibrahima Berthe; Siriman Traore; Ismaila Thera; Hadiata Maiga; Elisabeth Sogodogo; Karyn Coulibaly; Abdoulaye Guindo; Ousmane Dembele; Souleymane Sanogo; Zoumana Doumbia; Charles Dara; Mathias Altmann; Emmanuel Bonnet; Hubert Balique; Luis Sagaon-Teyssier; Laurent Vidal; Issaka Sagara; Marc Karim Bendiane; Jean Gaudart.
Affiliation
  • Mady Cissoko; IRD, INSERM, Aix Marseille Univ, SESSTIM, ISSPAM, Marseille, France; Malaria Research and Training Center, Universite des Sciences, Techniques et Technologies,
  • Jordi Landier; IRD, INSERM, Aix Marseille Univ, SESSTIM, ISSPAM, Marseille, France
  • Bourema Kouriba; Centre d'Infectiologie Clinique Charles Merieux, Bamako, Mali
  • Abdoul Karim Sangare; Centre d'Infectiologie Clinique Charles Merieux, Bamako, Mali
  • Abdoulaye Katile; IRD, INSERM, Aix Marseille Univ, SESSTIM, ISSPAM, Marseille, France; Malaria Research and Training Center, Universite des Sciences, Techniques et Technologies,
  • Abdoulaye Djimde; Malaria Research and Training Center, Universite des Sciences, Techniques et Technologies, Bamako, Mali
  • Ibrahima Berthe; Direction generale de la sante et de l'hygiene publique du ministere de la sante et du developpement social, Bamako, Mali
  • Siriman Traore; Malaria Research and Training Center, Universite des Sciences, Techniques et Technologies, Bamako, Mali
  • Ismaila Thera; Malaria Research and Training Center, Universite des Sciences, Techniques et Technologies, Bamako, Mali
  • Hadiata Maiga; Centre d'Infectiologie Clinique Charles Merieux, Bamako, Mali
  • Elisabeth Sogodogo; Centre d'Infectiologie Clinique Charles Merieux, Bamako, Mali
  • Karyn Coulibaly; Centre d'Infectiologie Clinique Charles Merieux, Bamako, Mali
  • Abdoulaye Guindo; Malaria Research and Training Center, Universite des Sciences, Techniques et Technologies, Bamako, Mali
  • Ousmane Dembele; Direction generale de la sante et de l'hygiene publique du ministere de la sante et du developpement social, Bamako, Mali
  • Souleymane Sanogo; Direction regionale de Tombouctou et etablissement public hospitalier de Tombouctou, Mali
  • Zoumana Doumbia; Direction regionale de Tombouctou et etablissement public hospitalier de Tombouctou, Mali
  • Charles Dara; Direction regionale de Tombouctou et etablissement public hospitalier de Tombouctou, Mali
  • Mathias Altmann; INSERM, IRD, Bordeaux Population Health, Bordeaux, France
  • Emmanuel Bonnet; IRD, Unite resilience, Paris, France
  • Hubert Balique; Direction generale de la sante et de l'hygiene publique du ministere de la sante et du developpement social, Bamako, Mali
  • Luis Sagaon-Teyssier; IRD, INSERM, Aix Marseille Univ, SESSTIM, ISSPAM, Marseille, France; ARCAD Sante Plus, Centre Integre de Recherche, de Soins et d'Action Communautaire, CIRSAC,
  • Laurent Vidal; IRD, INSERM, Aix Marseille Univ, SESSTIM, ISSPAM, Marseille, France
  • Issaka Sagara; Malaria Research and Training Center, Universite des Sciences, Techniques et Technologies, Bamako, Mali
  • Marc Karim Bendiane; IRD, INSERM, Aix Marseille Univ, SESSTIM, ISSPAM, Marseille, France
  • Jean Gaudart; Aix Marseille Univ, IRD, INSERM, SESSTIM, ISSPAM, AP-HM, Hop. La Timone, BioSTIC, Biostiatics and ICT, Marseille, France
Preprint in En | PREPRINT-MEDRXIV | ID: ppmedrxiv-22275924
ABSTRACT
ContextIn low-income settings where access to biological diagnosis is limited, data on the spread of the COVID-19 epidemic are scarce. In September 2020, after the first COVID-19 wave, Mali reported 3,086 confirmed cases and 130 deaths. Most reports originated form Bamako, the capital city, with 1,532 reported cases and 81 deaths for an estimated 2.42 million population. This observed prevalence of 0.06% appeared very low. Our objective was to estimate SARS-CoV-2 infection among inhabitants of Bamako, after the first epidemic wave. We also assessed demographic, social and living conditions, health behaviors and knowledge associated with SARS-CoV-2 seropositivity. Material and methodsWe conducted a cross-sectional multistage cluster household survey in commune VI, which reported, September 2020, 30% (n=466) of the total cases reported at Bamako. We measured serological status by detection of SARS-CoV-2 spike protein Antibodies in venous blood sampled after informed consent. We documented housing conditions and individual health behaviors through KABP questionnaires among participants aged 12 years and older. We estimated the number of SARS-CoV-2 infections and deaths in the total population of Bamako using the age and sex distributions of SARS-CoV-2 seroprevalence. A logistic generalized additive multilevel model was performed to estimate household conditions and demographic factors associated with seropositivity. ResultsWe recruited 1,526 inhabitants in the 3 investigated areas (commune VI, Bamako) belonging to the 306 sampled households. We obtained 1,327 serological results, 220 household questionnaires and collected KABP answers for 962 participants. The prevalence of SARS-CoV-2 seropositivity was 16.4% after adjusting on the population structure. This suggested that [~]400,000 cases and [~] 2,000 deaths could have occurred of which only 0.4% of cases and 5% of deaths were officially reported. KABP analyses suggested strong agreement with washing hands but lower acceptability of movement restrictions (lockdown or curfew), and limited mask wearing. ConclusionIn spite of limited numbers of reported cases, the first wave of SARS-CoV-2 spread broadly in Bamako. Expected fatalities remained limited largely due to the population age structure and the low prevalence of comorbidities. This highlight the difficulty of developing epidemic control strategies when screening test are not available or not used, even more when the transmission modalities are not well known by the population. Targeted policies based on health education prevention have to be implemented to improve the COVID-19 risk perception among the local population and fight to false knowledge and beliefs.
License
cc_by_nd
Full text: 1 Collection: 09-preprints Database: PREPRINT-MEDRXIV Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Rct Language: En Year: 2022 Document type: Preprint
Full text: 1 Collection: 09-preprints Database: PREPRINT-MEDRXIV Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Rct Language: En Year: 2022 Document type: Preprint